HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Xu Selected Research

Squamous Cell Carcinoma of Head and Neck

11/2021[Analysis of M2 macrophage infiltration and its clinical significance in 44 patients with multiple primary cancers of the head and neck].
7/2021High level of CD10 expression is associated with poor overall survival in patients with head and neck cancer.
6/2021[Dibenzyl trisulfide inhibits proliferation and induces apoptosis of HN30 cells via Akt/ p53 signaling pathway].
8/2019Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
1/2019MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.
3/2017[Preliminary study on the role of voltage-gated sodium channel subtype Nav1.5 in lymph node metastasis of oral squamous cell carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Xu Research Topics

Disease

70Neoplasms (Cancer)
06/2022 - 01/2000
24Inflammation (Inflammations)
03/2022 - 06/2000
17Infections
11/2021 - 10/2001
17Breast Neoplasms (Breast Cancer)
08/2021 - 06/2000
16Carcinoma (Carcinomatosis)
07/2021 - 03/2000
15Type 2 Diabetes Mellitus (MODY)
07/2018 - 11/2000
14Neoplasm Metastasis (Metastasis)
08/2021 - 01/2000
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 04/2000
12Ischemia
07/2018 - 12/2000
11Stomach Neoplasms (Stomach Cancer)
03/2021 - 04/2000
10Hemorrhage
03/2022 - 08/2001
9Hypoxia (Hypoxemia)
08/2021 - 06/2000
9Hepatocellular Carcinoma (Hepatoma)
01/2019 - 09/2000
8Aggressive Periodontitis (Periodontosis)
02/2022 - 06/2009
8Asthma (Bronchial Asthma)
12/2018 - 09/2000
8Prostatic Neoplasms (Prostate Cancer)
03/2018 - 10/2000
8Body Weight (Weight, Body)
12/2017 - 06/2001
7Lung Neoplasms (Lung Cancer)
08/2021 - 01/2000
7Vomiting
08/2021 - 05/2012
7Osteoarthritis
01/2017 - 09/2003
6Acidosis
03/2022 - 02/2000
6Squamous Cell Carcinoma of Head and Neck
11/2021 - 03/2017
6Adenocarcinoma
07/2021 - 08/2012
6Diabetes Mellitus
12/2018 - 11/2000
6Nausea
01/2018 - 05/2012
6Fibrosis (Cirrhosis)
12/2017 - 12/2000
6Stroke (Strokes)
07/2017 - 04/2001
6Nasopharyngeal Carcinoma
02/2017 - 01/2000
6Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 01/2014
5Colonic Neoplasms (Colon Cancer)
03/2022 - 05/2015
5Non-alcoholic Fatty Liver Disease
08/2021 - 01/2017
5Adenocarcinoma of Lung
01/2021 - 08/2015
5Tuberculosis (Tuberculoses)
09/2019 - 05/2001
5Carcinogenesis
09/2019 - 03/2000
5Hyperglycemia
12/2018 - 09/2000
5Reperfusion Injury
12/2018 - 06/2008
5Periodontitis
02/2013 - 07/2003
5Bullous Pemphigoid (Pemphigoid)
06/2001 - 01/2000
4Cognitive Dysfunction
01/2022 - 01/2015
4Lymphoma (Lymphomas)
12/2020 - 01/2000
4Infarction (Infarctions)
07/2020 - 02/2000
4Myocardial Infarction
07/2020 - 05/2001
4Thrombosis (Thrombus)
07/2020 - 04/2005
4Glioma (Gliomas)
02/2020 - 08/2001
4Chromosome Aberrations (Chromosome Abnormalities)
01/2020 - 07/2001
4Pneumonia (Pneumonitis)
09/2019 - 11/2006
4Wounds and Injuries (Trauma)
07/2019 - 03/2001
4Pain (Aches)
03/2018 - 01/2016
4Lymphatic Metastasis
02/2018 - 09/2006
4Autoimmune Diseases (Autoimmune Disease)
01/2018 - 01/2000

Drug/Important Bio-Agent (IBA)

37Proteins (Proteins, Gene)FDA Link
08/2021 - 01/2000
21Pharmaceutical PreparationsIBA
07/2022 - 01/2000
18DNA (Deoxyribonucleic Acid)IBA
03/2021 - 01/2000
16Glucose (Dextrose)FDA LinkGeneric
08/2021 - 06/2001
15Messenger RNA (mRNA)IBA
03/2017 - 04/2000
13Biomarkers (Surrogate Marker)IBA
03/2021 - 09/2006
10Biological ProductsIBA
08/2021 - 12/2006
10Sitagliptin Phosphate (Januvia)FDA Link
06/2015 - 11/2006
10AntigensIBA
01/2011 - 01/2000
9AutoantibodiesIBA
12/2020 - 01/2000
9Long Noncoding RNAIBA
10/2020 - 06/2014
8Oxygen (Dioxygen)IBA
03/2022 - 06/2000
8AntibodiesIBA
07/2021 - 01/2000
8CytokinesIBA
02/2019 - 07/2000
7Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 04/2001
7RNA (Ribonucleic Acid)IBA
01/2020 - 01/2000
7Phosphotransferases (Kinase)IBA
01/2018 - 03/2000
7Peptides (Polypeptides)IBA
01/2017 - 04/2000
7Metformin (Glucophage)FDA LinkGeneric
06/2015 - 03/2007
7Complementary DNA (cDNA)IBA
09/2007 - 01/2000
6MicroRNAs (MicroRNA)IBA
01/2021 - 01/2014
6Interleukin-6 (Interleukin 6)IBA
01/2017 - 03/2001
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 11/2000
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2011 - 03/2000
5Indicators and Reagents (Reagents)IBA
11/2021 - 08/2015
5LipidsIBA
08/2021 - 10/2001
5PlatinumIBA
11/2017 - 08/2014
5Therapeutic UsesIBA
01/2017 - 01/2000
5Monoclonal AntibodiesIBA
01/2016 - 04/2000
5Immunoglobulin G (IgG)IBA
12/2015 - 01/2000
5Matrix Metalloproteinases (MMPs)IBA
05/2006 - 01/2000
5EpitopesIBA
06/2001 - 01/2000
4CalciumIBA
06/2022 - 01/2016
4LigandsIBA
08/2021 - 07/2001
4human ERBB2 proteinIBA
03/2021 - 11/2017
4Docetaxel (Taxotere)FDA Link
03/2021 - 10/2001
4Hemoglobins (Hemoglobin)IBA
01/2021 - 11/2009
4Reactive Oxygen Species (Oxygen Radicals)IBA
03/2020 - 02/2001
4Interleukin-10 (Interleukin 10)IBA
01/2020 - 04/2007
4Triglycerides (Triacylglycerol)IBA
10/2019 - 01/2008
4Immunoglobulin E (IgE)IBA
12/2018 - 09/2000
4VaccinesIBA
12/2018 - 04/2001

Therapy/Procedure

58Therapeutics
04/2022 - 07/2000
19Drug Therapy (Chemotherapy)
08/2019 - 07/2001
9Transplantation
12/2018 - 08/2001
8Aftercare (After-Treatment)
02/2020 - 09/2000
6Radiotherapy
04/2019 - 07/2001
4Neoadjuvant Therapy
06/2022 - 07/2017
4Colectomy
03/2022 - 11/2018
4Kidney Transplantation
04/2019 - 06/2008